Johns, J.S.; Krogh, K.; Ethans, K.; Chi, J.; Querée, M.; Eng, J.J.; Spinal Cord Injury Research Evidence Team.
Pharmacological Management of Neurogenic Bowel Dysfunction after Spinal Cord Injury and Multiple Sclerosis: A Systematic Review and Clinical Implications. J. Clin. Med. 2021, 10, 882.
https://doi.org/10.3390/jcm10040882
AMA Style
Johns JS, Krogh K, Ethans K, Chi J, Querée M, Eng JJ, Spinal Cord Injury Research Evidence Team.
Pharmacological Management of Neurogenic Bowel Dysfunction after Spinal Cord Injury and Multiple Sclerosis: A Systematic Review and Clinical Implications. Journal of Clinical Medicine. 2021; 10(4):882.
https://doi.org/10.3390/jcm10040882
Chicago/Turabian Style
Johns, Jeffery S, Klaus Krogh, Karen Ethans, Joanne Chi, Matthew Querée, Janice J Eng, and Spinal Cord Injury Research Evidence Team.
2021. "Pharmacological Management of Neurogenic Bowel Dysfunction after Spinal Cord Injury and Multiple Sclerosis: A Systematic Review and Clinical Implications" Journal of Clinical Medicine 10, no. 4: 882.
https://doi.org/10.3390/jcm10040882
APA Style
Johns, J. S., Krogh, K., Ethans, K., Chi, J., Querée, M., Eng, J. J., & Spinal Cord Injury Research Evidence Team.
(2021). Pharmacological Management of Neurogenic Bowel Dysfunction after Spinal Cord Injury and Multiple Sclerosis: A Systematic Review and Clinical Implications. Journal of Clinical Medicine, 10(4), 882.
https://doi.org/10.3390/jcm10040882